Statistical flag only — not an accusation of fraud
⚠️ This provider averages 923 services per working day — physically unusual for an individual practitioner
Based on 2.3M total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $29.3M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.
Averaging 923 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 350% from 2014 to 2023.
This provider has been statistically flagged with a risk score of 67/100. Statistical flags are not accusations of fraud.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 83% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $40.72 | $14.09 | 2.89x | $26.63 | $985.8K | 70.0K | 44 |
| 2015 | $37.21 | $12.40 | 3.00x | $24.81 | $1.8M | 145.8K | 50 |
| 2016 | $24.42 | $8.48 | 2.88x | $15.94 | $2.4M | 286.9K | 57 |
| 2017 | $26.84 | $9.81 | 2.74x | $17.03 | $2.8M | 286.3K | 53 |
| 2018 | $35.59 | $14.98 | 2.38x | $20.61 | $3.6M | 238.8K | 59 |
| 2019 | $31.97 | $13.42 | 2.38x | $18.55 | $3.5M | 262.6K | 57 |
| 2020 | $32.57 | $13.00 | 2.51x | $19.57 | $3.3M | 256.2K | 58 |
| 2021 | $34.87 | $13.50 | 2.58x | $21.37 | $2.8M | 210.9K | 46 |
| 2022 | $37.91 | $14.55 | 2.61x | $23.36 | $3.6M | 246.9K | 58 |
| 2023 | $52.73 | $14.65 | 3.60x | $38.08 | $4.4M | 302.6K | 59 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J9299 | Injection, nivolumab, 1 mg | 228.9K | $5.1M | $22.20 | 2.16x |
| J9271 | Injection, pembrolizumab, 1 mg | 116.4K | $4.8M | $41.56 | 2.23x |
| J2505 | Injection, pegfilgrastim, 6 mg | 588 | $1.8M | $3.1K | 1.97x |
| J0897 | Injection, denosumab, 1 mg | 114.5K | $1.7M | $14.93 | 2.07x |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 1.2K | $1.2M | $1.0K | 2.73x |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | 15.7K | $1.2M | $74.26 | 2.19x |
| J9041 | Injection, bortezomib, 0.1 mg | 32.2K | $1.0M | $31.79 | 2.80x |
| J1930 | Injection, lanreotide, 1 mg | 22.3K | $959.4K | $43.04 | 2.59x |
| J9310 | Injection, rituximab, 100 mg | 1.5K | $918.9K | $620.44 | 2.13x |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 7.4K | $723.5K | $97.81 | 2.96x |
| J9035 | Injection, bevacizumab, 10 mg | 10.5K | $632.0K | $60.13 | 2.07x |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 70.3K | $598.0K | $8.50 | 2.29x |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 65.5K | $564.9K | $8.63 | 3.74x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 6.2K | $505.9K | $81.85 | 1.78x |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 3.1K | $489.9K | $158.23 | 4.23x |
| Q5115 | Injection, rituximab-abbs, biosimilar, (truxima), 10 mg | 10.0K | $467.5K | $46.94 | 3.52x |
| J9022 | Injection, atezolizumab, 10 mg | 6.3K | $402.1K | $63.94 | 2.52x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 7.2K | $372.5K | $51.93 | 1.89x |
| J2469 | Injection, palonosetron hcl, 25 mcg | 26.8K | $340.9K | $12.72 | 6.12x |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 10.9K | $324.8K | $29.77 | 4.62x |
This provider submits charges 2.76 times higher than what Medicare actually pays.
A markup ratio of 2.76x means for every $100 Medicare pays, this provider initially charges $276. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in KS for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Pavan Reddy, M.D. | Wichita, KS | $52.9M | ⚠️ Flagged |
| Bassam Mattar, MD | Wichita, KS | $50.2M | ⚠️ Flagged |
| Dennis Moore, MD | Wichita, KS | $44.1M | ⚠️ Flagged |
| Shaker Dakhil, MD | Wichita, KS | $41.0M | ⚠️ Flagged |
| Jeremy Deutsch, MD | Wichita, KS | $39.7M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data